PCRX

SEC source: 0001628280-26-005153 · wk-form4_1770161015.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,012.841

F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

SEC source: 0001628280-26-004188 · wk-form4_1769723829.xml · derivative · entry 1

Hirawat Samit · CIK 0001781290 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,291

Underlying: Common Stock · 39,291 shares

Expires 2036-01-27

F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

SEC source: 0001628280-26-000967 · wk-form4_1767738641.xml · nonDerivative · entry 2

RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,064.242

F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001628280-26-000968 · wk-form4_1767738651.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,523.175

F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

F2 · balance_after: Includes 537.166 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.

SEC source: 0001628280-26-000967 · wk-form4_1767738641.xml · nonDerivative · entry 1

RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,480.242

F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

F2 · balance_after: Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.

SEC source: 0001628280-26-000966 · wk-form4_1767738633.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 440,500.841

F1 · shares: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

F2 · balance_after: Includes 1,363.841 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025.

SEC source: 0001628280-26-000964 · wk-form4_1767738624.xml · nonDerivative · entry 1

Teehan Brendan · CIK 0001891900 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,402.268

F1 · shares: Represents shares of common stock acquired under the issuer's employee stock purchase plan in December 2025.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · derivative · entry 6

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 9,104 shares

Expires 2034-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · nonDerivative · entry 4

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,250

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.30, inclusive.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · nonDerivative · entry 3

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · derivative · entry 5

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,104

Underlying: Common Stock · 15,896 shares

Expires 2034-11-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · nonDerivative · entry 2

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,250

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3.

SEC source: 0001628280-25-056645 · wk-form4_1765507617.xml · nonDerivative · entry 1

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001628280-25-053205 · wk-form4_1763587920.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,367.009

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001628280-25-052038 · wk-form4_1763068400.xml · nonDerivative · entry 1

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,250

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001628280-25-048393 · wk-form4_1762209691.xml · nonDerivative · entry 1

Cross Shawn · CIK 0001734779 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,310

F1 · kind: Represents shares withheld by the issuer to cover tax obligations upon the vesting of restricted stock units.

SEC source: 0001396814-25-000109 · wk-form4_1757367430.xml · nonDerivative · entry 1

Ceesay Abraham · CIK 0001722140 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,039

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001396814-25-000107 · wk-form4_1754942983.xml · nonDerivative · entry 1

BIGAL MARCELO · CIK 0001996637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,393

SEC source: 0001396814-25-000095 · wk-form4_1754339458.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,327.009

F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

F2 · balance_after: Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025.

SEC source: 0001396814-25-000085 · wk-form4_1749845889.xml · derivative · entry 2

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000085 · wk-form4_1749845889.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,636

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000080 · wk-form4_1749845835.xml · derivative · entry 2

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000080 · wk-form4_1749845835.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,715

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000087 · wk-form4_1749845910.xml · derivative · entry 2

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000087 · wk-form4_1749845910.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,901

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000086 · wk-form4_1749845900.xml · derivative · entry 2

Ceesay Abraham · CIK 0001722140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000086 · wk-form4_1749845900.xml · nonDerivative · entry 1

Ceesay Abraham · CIK 0001722140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,393

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000084 · wk-form4_1749845879.xml · derivative · entry 2

BIGAL MARCELO · CIK 0001996637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000084 · wk-form4_1749845879.xml · nonDerivative · entry 1

BIGAL MARCELO · CIK 0001996637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,305

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000083 · wk-form4_1749845868.xml · derivative · entry 2

YANG MICHAEL J. · CIK 0001702283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000083 · wk-form4_1749845868.xml · nonDerivative · entry 1

YANG MICHAEL J. · CIK 0001702283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,393

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000082 · wk-form4_1749845857.xml · derivative · entry 2

CHRISTIE CHRISTOPHER · CIK 0001787688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000082 · wk-form4_1749845857.xml · nonDerivative · entry 1

CHRISTIE CHRISTOPHER · CIK 0001787688 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,654

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000081 · wk-form4_1749845846.xml · derivative · entry 2

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,279

Underlying: Common Stock · 11,279 shares

Expires 2035-06-11

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date.

SEC source: 0001396814-25-000081 · wk-form4_1749845846.xml · nonDerivative · entry 1

Young Alethia · CIK 0001918147 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,393

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001628280-26-019892 · wk-form4a_1773956593.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,065

F1 · shares: Represents restricted stock units that vest on June 11, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000068 · wk-form4_1749159376.xml · nonDerivative · entry 2

WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,574

SEC source: 0001396814-25-000069 · wk-form4_1749159397.xml · nonDerivative · entry 2

RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,564

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2.

SEC source: 0001396814-25-000067 · wk-form4_1749159413.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,959.511

F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

SEC source: 0001396814-25-000068 · wk-form4_1749159376.xml · nonDerivative · entry 1

WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,950

F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

SEC source: 0001396814-25-000069 · wk-form4_1749159397.xml · nonDerivative · entry 1

RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,142.335

F1 · kind: Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

SEC source: 0001396814-25-000030 · wk-form4_1738711527.xml · derivative · entry 2

Teehan Brendan · CIK 0001891900 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,500

Underlying: Common Stock · 99,500 shares

Expires 2036-02-04

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

SEC source: 0001396814-25-000033 · wk-form4_1738711558.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,043.511

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000032 · wk-form4_1738711548.xml · nonDerivative · entry 1

WILLIAMS KRISTEN · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,112

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000031 · wk-form4_1738711538.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 448,409

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000030 · wk-form4_1738711527.xml · nonDerivative · entry 1

Teehan Brendan · CIK 0001891900 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,000

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000029 · wk-form4_1738711516.xml · nonDerivative · entry 1

RIKER LAUREN · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,516.335

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on February 1, 2026, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

SEC source: 0001396814-25-000007 · wk-form4_1736205784.xml · nonDerivative · entry 2

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,443.511

F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

SEC source: 0001396814-25-000007 · wk-form4_1736205784.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,322.511

F1 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

F2 · balance_after: Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024.

SEC source: 0001396814-25-000008 · wk-form4_1736205793.xml · nonDerivative · entry 1

Lee Frank D. · CIK 0001814686 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,409

F1 · kind: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.